Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients

NCT06916585 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Acute-On-Chronic Liver Failure

Interventions

DRUG: AS1501 for injection

Sponsor

Shenzhen Third People's Hospital

Collaborators

[object Object]
[object Object]